Yan BB, Cheng LN, Yang H, Li XL, Wang XQ. Comprehensive analysis of risk factors associated with submucosal invasion in patients with early-stage gastric cancer. World J Gastroenterol 2024; 30(47): 5007-5017 [DOI: 10.3748/wjg.v30.i47.5007]
Corresponding Author of This Article
Xiu-Qi Wang, MM, Doctor, Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, No. 7 Weiwu Road, Jinshui District, Zhengzhou 450000, Henan Province, China. xiuqiwang00123@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 21, 2024; 30(47): 5007-5017 Published online Dec 21, 2024. doi: 10.3748/wjg.v30.i47.5007
Table 1 Baseline characteristics of patients with early-stage differentiated gastric cancer
Characteristic
n (%)
Total patients
268
Gender
Male
199 (72.3)
Female
69 (25.7)
Age (years)
mean ± SD
61.5 ± 9.8
Age range
30-83
Age ≥ 60 years
192 (71.6)
Lifestyle factors
History of alcohol consumption
143 (53.4)
History of smoking
152 (56.7)
Family history of gastric cancer
37 (13.8)
Clinical assessments
Anemia
12 (4.5)
Positive fecal occult blood test
60 (22.4)
Elevated CEA
19 (7.1)
Imaging findings
CT showing gastric wall thickening
111 (41.4)
CT showing lymph node enlargement
34 (12.7)
Endoscopic characteristics
Lesion location
Upper third of the stomach
87 (32.5)
Middle third of the stomach
41 (15.3)
Lower third of the stomach
140 (52.2)
Gross morphology
Elevated type
144 (53.7)
Flat type
51 (19.0)
Depressed type
73 (27.2)
Table 2 Univariate analysis of clinical and endoscopic characteristics between patients with submucosal and mucosal gastric cancer, n (%)
Characteristic
Submucosal invasion (n = 71)
Mucosal invasion (n = 197)
χ² (t, Z) value
P value
OR (95%CI)
P value
Demographics and medical history
Male
61 (85.9)
138 (70.1)
χ² = 1.509
0.122
1.90 (0.70-5.75)
0.228
Age ≥ 60 years
52 (73.2)
140 (71.1)
χ² = 0.251
0.615
0.85 (0.31-2.75)
0.634
Age (years)
62.9 ± 10.5
64.3 ± 10.2
t = 1.132
0.272
0.94 (0.91-1.23)
0.352
Alcohol history
43 (60.6)
100 (50.8)
χ² = 4.738
< 0.05
2.25 (1.25-5.94)
< 0.05
Smoking history
45 (63.4)
107 (54.3)
χ² = 4.342
< 0.05
2.56 (1.15-6.44)
< 0.05
Family history of gastric cancer
10 (14.1)
27 (13.7)
χ² = 0.314
0.532
0.63 (0.33-1.97)
0.517
Clinical and imaging findings
Anemia
4 (5.6)
8 (4.1)
χ² = 0.342
0.643
2.55 (0.45-11.82)
0.275
Positive fecal occult blood test
16 (22.5)
44 (22.3)
χ² = 0.692
0.548
0.58 (0.28-1.23)
0.462
Elevated CEA
4 (5.6)
15 (7.6)
χ² = 0.012
0.913
1.39 (0.63-6.34)
0.649
CT showing gastric wall thickening
42 (59.2)
69 (35.0)
χ² = 6.784
< 0.05
3.10 (1.40-7.25)
0.026
CT showing lymph node enlargement
16 (22.5)
18 (9.1)
χ² = 2.954
0.107
3.21 (0.85-8.96)
0.109
Endoscopic characteristics
Tumor location: Upper third
51 (71.8)
36 (18.3)
χ² = 28.231
< 0.01
18.25 (6.41-56.16)
< 0.001
Middle third
10 (14.1)
31 (15.7)
Lower third of the stomach
10 (14.1)
130 (66.0)
Gross type: Elevated type
17 (23.9)
127 (47.4)
χ² = 18.400
< 0.001
5.50 (2.19-14.32)
< 0.01
Flat type
14 (19.7)
37 (18.8)
Depressed type
40 (56.3)
33 (16.8)
Lesion diameter ≥ 20 mm
16 (22.5)
44 (22.3)
χ² = 3.741
0.052
2.46 (0.96-5.82)
0.072
Lesion diameter (mm)
20 (12, 32)
15 (13, 21)
Z = 1.742
0.071
1.13 (0.97-1.15)
0.089
Spontaneous bleeding
6 (8.5)
21 (10.7)
χ² = 0.274
0.795
1.53 (0.54-4.69)
0.579
Central depression
9 (12.7)
33 (16.8)
χ² = 0.894
0.324
1.67 (0.64-4.86)
0.371
Gastric wall rigidity
8 (11.3)
12 (6.1)
χ² = 0.505
0.493
2.63 (0.89-30.25)
0.517
Marginal elevation
26 (36.6)
28 (14.2)
χ² = 10.646
0.002
4.10 (1.58-9.65)
0.006
Fold changes
12 (16.9)
16 (8.1)
χ² = 3.774
0.081
11.83 (3.25-35.61)
0.018
Presence of ulcer
12 (16.9)
48 (24.3)
χ² = 2.773
0.103
1.75 (0.78-4.03)
0.254
Surface roughness
44 (62.0)
126 (64.0)
χ² = 1.222
0.243
1.58 (0.70-4.15)
0.302
WLE color difference ≥ 12.6
30 (42.3)
82 (41.6)
χ² = 9.500
< 0.01
5.00 (1.66-12.77)
< 0.01
WLE color difference
18.1 (12.6, 20.3)
13.2 (9.8, 22.1)
Z = 3.630
< 0.01
1.40 (1.14-1.58)
< 0.01
LCI color difference ≥ 18.1
51 (71.8)
95 (48.2)
χ² = 11.731
< 0.01
4.27 (1.82-10.11)
< 0.01
LCI color difference
26.8 (19.1, 34.2)
18.6 (14.1, 23.1)
Z = 3.226
< 0.01
1.13 (0.96-1.06)
< 0.01
Table 3 Multivariate logistic regression analysis of predictors for submucosal invasion in gastric cancer
Characteristic
β value
Standard error
Wald χ² value
P value
OR (95%CI)
Tumor located in upper 2/3 of stomach
1.622
0.403
18.542
< 0.001
5.268 (2.434-10.984)
Depressed type
1.846
0.689
7.625
0.006
5.841 (1.745-21.243)
Marginal elevation
1.398
0.624
4.662
0.027
4.132 (1.235-15.869)
LCI color difference ≥ 18.1
1.489
0.672
5.427
0.021
4.479 (1.274-14.856)
Table 4 Receiver operating characteristic analysis of predictive indicators for submucosal invasion
Indicator
AUC (95%CI)
Youden index maximum cutoff
Selected cutoff
Sensitivity at cutoff
Specificity at cutoff
Lesion diameter
0.630 (0.462-0.712)
26.80
21.1
0.593
0.582
WLE color difference
0.799 (0.642-0.842)
14.2
13.1
0.823
0.484
LCI color difference
0.760 (0.571-0.791)
19.9
17.3
0.788
0.448
Citation: Yan BB, Cheng LN, Yang H, Li XL, Wang XQ. Comprehensive analysis of risk factors associated with submucosal invasion in patients with early-stage gastric cancer. World J Gastroenterol 2024; 30(47): 5007-5017